Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review: The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses
Eric A. Meyerowitz, Yijia Li
Clinical Infectious Diseases (2023) Vol. 78, Iss. 4, pp. 908-917
Open Access | Times Cited: 10

Showing 10 citing articles:

SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
Fabrizio Angius, Silvia Puxeddu, S Zaimi, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 4
The evolving landscape of COVID-19: factors associated with in-hospital COVID-19 related mortality during the 2023–2024 phase of JN.1 subvariant dominance
Drieda Zaçe, Albiana Çekrezi, Christopher M. Jones, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Preliminary results and a theoretical perspective of co‑treatment using a miR‑93‑5p mimic and aged garlic extract to inhibit the expression of the pro‑inflammatory interleukin‑8 gene
Roberto Gambari, Chiara Papi, Jessica Gasparello, et al.
Experimental and Therapeutic Medicine (2025) Vol. 29, Iss. 4, pp. 1-11
Open Access
Clinical Manifestations of SARS-CoV-2 Infection in Immunocompetent Adults in the Era of Widespread Population Immunity and Omicron Sublineage Viruses
Alexander Shaffer, Eric A. Meyerowitz
Infectious Disease Clinics of North America (2025)
Closed Access
Case Report: Persistent COVID-19 in a fully vaccinated Japanese man being treated with rituximab and epcoritamab for diffuse large B-cell lymphoma
Masaki Suzuki, Isao Fujioka, Takamitsu Matsushima
Frontiers in Medicine (2025) Vol. 12
Open Access
Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity and Prevents Selection for Nirmatrelvir/Ritonavir Resistance Mutations
Shuntai Zhou, Nathan Long, Kyle Rosenke, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 6, pp. 1380-1383
Closed Access | Times Cited: 3
Open Source Repurposing Reveals Broad-Spectrum Antiviral Activity of Diphenylureas
Ulrich Betz, Robert Garces, Norbert Beier, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 385-385
Open Access
Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment
José Aguareles, Paula Villares Fernández, Carles Forné, et al.
Infectious Diseases (2024) Vol. 56, Iss. 7, pp. 575-580
Open Access | Times Cited: 1
Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus
Cong Wu, Qi Jiang, Hui Zhong, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 1
The consequences of SARS-CoV-2 within-host persistence
Alex Sigal, Richard A. Neher, Richard Lessells
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 1
A comprehensive review on targeting cluster of differentiation: An attractive strategy for inhibiting viruses through host proteins
Youle Zheng, Feng Jin, Min Ling, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 132200-132200
Closed Access
Page 1

Scroll to top